top stock gainers today August 5 2026

Wednesday’s market was split down the middle. The Dow climbed 0.79%. The Nasdaq fell over 100 points. SpaceX cratered 11%. Uber’s guidance disappointed. But in pockets of the market, a completely different story was being written — driven by genuine earnings beats, raised guidance, and AI-powered business model transformations that are delivering actual revenue growth.

These are the 10 biggest winners of August 5, 2026.

The Wednesday Macro Context

Index / AssetMoveNote
Dow Jones+0.79%Defensive names and select earnings beats lifted it
Nasdaq Composite-100+ pointsSpaceX, AMD, Snap, Uber dragged tech lower
WTI Crude Oil-0.4%Continuing yesterday’s 5% collapse; oil deflation story persists
Gold+2.5%Safe-haven demand picks up as tech bleeds
Earnings themeSplit verdictBeats rewarded, guidance misses punished instantly

The divergence is clear: companies that delivered on earnings got bought hard. Companies that missed forward guidance — even slightly — got sold just as hard.

#1 — APPS (Digital Turbine Inc.) | +32.60% to $12.61 — The AI-Powered Ad Tech Comeback

52-week High: $13.60 | 52-week Low: $2.74 | Market Cap: $1.15B

This is Wednesday’s standout smaller-cap winner. Digital Turbine — a mobile app distribution and advertising platform — reported Q1 FY2027 results that blew past every estimate and then followed up by raising full-year guidance significantly above consensus.

Q1 FY2027 Results vs. Expectations:

MetricActualEstimateBeat
EPS$0.17$0.14+21% beat
Revenue$142.5 million~$129M estimate+10%+ beat
AGP Revenue Growth (YoY)+56%Exceptional
ODS Revenue Growth (YoY)+15%Solid
International ODS Growth+80%Acceleration
Direct Brand Revenue Growth+70%Strongest segment
DTX (exchange) Growth+40%+Both SSP and DTX

Raised FY2027 Full-Year Guidance:

  • Revenue: $650M–$670M (vs. prior street estimate of approximately $600M)
  • Adjusted EBITDA: $145M–$155M (significant margin expansion implied)

Balance sheet improvements cited:

  • Net leverage reduced to 2.5x (from higher levels; 50 bps margin reduction on largest loan tranche)
  • Debt reduced by more than $8 million during the quarter
  • Operating cash flow: $17.9 million

The AI angle: Management explicitly attributed growth to AI tools embedded in its Ignite platform, first-party data monetization via the DT Ignite Graph, and alternative app distribution expansion. This isn’t AI hype — it’s AI-driven advertising performance showing up in the P&L.

The stock was trading near its 52-week high of $13.60 with this move. The prior 52-week low of $2.74 underscores just how far this recovery has come.

#2 — SHOP (Shopify Inc.) | +19.64% to $147.52 — The E-Commerce Platform Accelerating Into AI

52-week High: $182.19 | 52-week Low: $94.00 | Market Cap: $160B

Shopify’s Q2 2026 results, released before Wednesday’s open, delivered one of the most comprehensive beats of the quarter — across every metric that matters.

Q2 2026 vs. Expectations:

MetricActualEstimateBeat
Revenue$3.58 billion$3.45 billion+4.36%
YoY Revenue Growth+33.7%+28-29% expectedSignificant
EPS$0.42$0.39+7.69%
YoY EPS Growth+20%+11.4% expectedDoubled the bar
GMV$115.57 billion+32% YoY
Merchant Solutions Revenue$2.78 billion+37% YoY
Subscription Solutions Revenue$802 million+22% YoY
Operating Income$488 million+68% YoY
Free Cash Flow$654 million18% FCF margin

Q3 2026 Forward Guidance:

  • Revenue growth: low-thirties % year-over-year — above the 26.3% analyst consensus
  • FCF margin: high-teens to low-twenties % — expanding further

CFO Jeff Hoffmeister: “Broad-based, consistent, and compounding growth with financial discipline — that’s exactly the model that we’ve been building.”

The AI acceleration detail: Benzinga highlighted that “AI-driven orders are tripling” and “new buyers arrive nearly twice as fast” on Shopify’s platform — a direct attribution of AI-powered merchant tooling to improved conversion and acquisition metrics. This isn’t theoretical; it’s showing up in the GMV numbers.

The one bear note: Rothschild & Co. Redburn downgraded SHOP to Neutral in July, citing Meta’s push into AI tools for small businesses as a competitive threat. The market is dismissing that for now.

#3 — BLMN (Bloomin’ Brands Inc.) | +31-35% to $11.69-$12.03 — The Casual Dining Turnaround Nobody Saw Coming

What it is: Bloomin’ Brands operates Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse — four casual dining brands with roughly 1,450 restaurants globally.

This is Wednesday’s most surprising sector winner. Casual dining has been under pressure from persistent consumer caution, elevated food costs, and competition from fast-casual alternatives. Bloomin’ Brands just said: not for us.

Q2 2026 Results:

  • Beat consensus on both revenue and EPS
  • Raised FY26 EPS guidance — a direct signal that management sees the improvement as durable
  • The stock was trading near its 52-week lows before the report; the +35% move represents a complete narrative reset

The macro tailwind: With WTI crude falling 5% yesterday and continuing lower today, the full-service restaurant industry gets a significant fuel and logistics cost tailwind. Bloomin’ Brands benefits directly through lower delivery, packaging, and supply chain costs.

#4 — LLY (Eli Lilly and Company) | Beats Q2 Estimates — GLP-1 Empire Holds

Eli Lilly beat Q2 2026 earnings estimates — maintaining its position as the most valuable pharmaceutical company in the world on the strength of Mounjaro (tirzepatide) and Zepbound.

Key Q2 themes:

  • GLP-1 weight loss drug revenue: still the dominant growth driver
  • Manufacturing capacity expansion: a necessary unlock for continued revenue growth
  • Pipeline depth: donanemab (Alzheimer’s), elebresib (cancer) advancing through clinical stages

Context: LLY had guided cautiously heading into Q2 given manufacturing constraints and Medicare drug pricing negotiations. The beat shows demand continues to absorb every unit of supply the company can produce.

#5 — FTK (Flotek Industries Inc.) | +27-29% to $35.75 — The Oilfield Chemistry Comeback

Market Cap: Small cap | Catalyst: Q2 2026 beat + raised FY26 sales guidance above estimates

Flotek Industries — which provides chemistry-driven solutions for oilfield services and industrial markets — delivered a Q2 beat that significantly exceeded Wall Street’s expectations and then raised its full-year revenue guidance above the prior analyst consensus.

Why it matters today:

  • With crude oil down 5% yesterday (Iran peace deal), the energy sector was broadly under pressure — making Flotek’s beat even more impressive
  • The raised guidance implies the company’s chemistry solutions for water treatment and reservoir management are gaining share regardless of short-term oil price moves
  • Volume: 29.4% to $36.50 per Benzinga — one of the largest percentage moves among any name in the energy services space today

#6 — DT (Dynatrace Inc.) | +13.2% to $51.76 — Software Observability Surprises to the Upside

What it does: Dynatrace provides AI-powered software intelligence and observability — monitoring and optimizing complex cloud environments in real time.

Q2 2026 Results:

  • Quarterly revenue: Beat consensus estimates
  • FY27 adjusted EPS guidance: Raised above estimates — the guidance raise is the key market-moving metric here
  • Growth driver: AI-powered anomaly detection and automated root cause analysis products gaining enterprise adoption across Fortune 500 customers

Why it’s rising in a Nasdaq-down day: Dynatrace is proving that enterprise AI spending on observability and monitoring is durable even as Nasdaq growth names broadly sell off. Its SaaS subscription model provides visible, recurring revenue that doesn’t depend on macro tailwinds.

#7 — ANET (Arista Networks) | +10.3% — $3.3 Billion Q3 Revenue Guidance Is the Tell

Context: Arista Networks raised its Q3 2026 revenue guidance to $3.3 billion — a figure that meaningfully exceeded analyst expectations and validated the AI networking thesis that has been driving the stock higher all year.

The AI networking story: Arista builds the switches and routers that move data between GPU clusters in AI data centers. As AI compute spending accelerates — and both SpaceX’s Q2 capex of $15.8B on AI infrastructure and Shopify’s AI-driven order growth confirm this trend is real — network infrastructure demand grows proportionally. Arista is the primary beneficiary of that demand acceleration in the data center networking segment.

#8 — CRL (Charles River Laboratories International) | +11% to $260 — Pharma Enabler Has a Strong Quarter

What it does: Charles River provides essential research and testing services for drug developers — preclinical research, safety testing, and manufacturing support.

Q2 2026 Results:

  • Beat consensus on both revenue and EPS
  • Raised FY26 guidance — the most important signal for a contract research organization (CRO)
  • Beneficiary of Eli Lilly’s and Novo Nordisk’s expanded drug development pipelines, which require significant external CRO support

The raised guidance is particularly meaningful: CROs have forward revenue visibility through multi-year contracts. When Charles River raises guidance, it’s because signed contracts are running ahead of initial project schedules.

#9 — FUBO (fuboTV Inc.) | +6.28% to $10.15 — Profitability Story Wins Despite Revenue Slip

52-week High: $56.64 | 52-week Low: $7.95 | Market Cap: $1.04B

fuboTV’s Q2 2026 results were technically a revenue miss — but the market is looking past that. Here’s why the stock is up.

Q2 2026: The Real Story
MetricActualEstimateBeat/Miss
Revenue$1.48 billion$1.50 billion-1.1% (minor miss)
YoY Revenue Growth+35.8%Still impressive
GAAP EPS-$0.25-$0.38+34.2% beat
Adjusted EBITDA$19.14 million$12.84 million+49% beat
Free Cash Flow-$7.48 million-$41.38M prior QDramatically improved
Domestic SubscribersUp 4.39 million YoYSubscriber momentum
FY26 EBITDA Guidance (midpt)$95 million$92.32M estimateAbove consensus

The profitability trajectory is the story. FCF improved from -$41.38M to -$7.48M in a single quarter — a $34M improvement that puts fuboTV within striking distance of cash flow breakeven. The market is pricing in the path to profitability, not the current quarter’s revenue shortfall.

#10 — REPL (Replimune Group Inc.) | +1.01% to $12.04 — Biotech Holds as Sector Rotates

52-week High: $13.86 | 52-week Low: $1.50 | Market Cap: $1B

Replimune is trending not because it’s the day’s biggest mover, but because it’s one of the few healthcare names holding positive ground while the Nasdaq drops 100+ points. The company’s oncolytic immunotherapy platform — using engineered viruses to fight solid tumors — is gaining clinical validation across multiple cancer types.

Why it’s worth watching:

  • The 52-week low of $1.50 vs. the current $12.04 represents a +700% recovery over the past year
  • With gold up 2.5% and risk assets under pressure today, defensive healthcare with a binary catalyst pipeline is a natural rotation destination
  • Replimune’s lead program RP1 (vusolimogene oderparepvec) has significant FDA catalyst potential in the next 12 months

The Winning Theme of August 5, 2026

Today’s gains share a common thread: every top gainer either beat earnings estimates materially, raised forward guidance above consensus, or both. The market in August 2026 is ruthlessly separating companies that deliver from companies that disappoint. SHOP, APPS, BLMN, FTK, DT, CRL — all beat and raised. All surged. The lesson is direct.

On a day when SpaceX fell 11% and the Nasdaq lost 100 points, these companies proved that earnings quality is the ultimate market protection.

Follow TNN for daily stock market news and financial news today.


Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Always complete independent due diligence prior to executing equity trades.

Real-time gainers at Yahoo Finance Gainers | Shopify results at Shopify IR | Earnings calendar at TipRanks Earnings

About The Author